Results
24
Financially healthy companies listed on Asian stock exchanges with an impressive track record.
24 companies
Torrent Pharmaceuticals
Market Cap: ₹1.1t
Engages in the research, development, manufacturing, and marketing of generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally.
500420
₹3,143.95
7D
-0.7%
1Y
13.0%
WuXi XDC Cayman
Market Cap: HK$50.6b
An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.
2268
HK$41.00
7D
2.1%
1Y
164.5%
Shanghai Allist Pharmaceuticals
Market Cap: CN¥43.4b
Shanghai Allist Pharmaceuticals Co., Ltd.
688578
CN¥94.48
7D
-1.2%
1Y
48.7%
Gan & Lee Pharmaceuticals
Market Cap: CN¥34.2b
A biopharmaceutical company, engages in the research, development, production, and sale of insulin analog active pharmaceutical ingredients (APIs) and injections in China.
603087
CN¥56.66
7D
2.8%
1Y
18.9%
Xiamen Amoytop Biotech
Market Cap: CN¥30.5b
Engages in research, development, production, and sale of recombinant protein drugs in China.
688278
CN¥74.59
7D
-7.8%
1Y
39.8%
Ipca Laboratories
Market Cap: ₹354.1b
A pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India, Europe, Africa, the Americas, Asia, CIS, and Australasia.
IPCALAB
₹1,386.00
7D
-5.7%
1Y
19.3%
J. B. Chemicals & Pharmaceuticals
Market Cap: ₹264.6b
Manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally.
506943
₹1,697.40
7D
0.3%
1Y
-4.0%
Emcure Pharmaceuticals
Market Cap: ₹252.8b
Engages in the developing, manufacturing, and marketing pharmaceutical products worldwide.
EMCURE
₹1,332.40
7D
-1.4%
1Y
n/a
Concord Biotech
Market Cap: ₹196.3b
A biopharma company, engages in the research and development, manufacturing, marketing, and sale of pharmaceutical products in India and internationally.
CONCORDBIO
₹1,850.70
7D
11.0%
1Y
26.2%
Caplin Point Laboratories
Market Cap: ₹163.9b
Engages in the development, production, marketing, and export of generic pharmaceutical formulations and branded products in India.
524742
₹2,119.40
7D
-2.0%
1Y
62.6%
Blue Jet Healthcare
Market Cap: ₹157.5b
Engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products.
BLUEJET
₹923.65
7D
4.1%
1Y
147.8%
Sai Life Sciences
Market Cap: ₹152.1b
Operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally.
SAILIFE
₹731.50
7D
2.1%
1Y
n/a
Jiangsu Sinopep-Allsino Biopharmaceutical
Market Cap: CN¥11.3b
A biomedical company, engages in the research and development, production, sale, and technical service of peptides and small molecule drugs in China.
688076
CN¥50.13
7D
2.7%
1Y
-13.2%
Marksans Pharma
Market Cap: ₹116.4b
Engages in the research, manufacturing, marketing, and sale of pharmaceutical formulations in the United States, North America, Europe, the United Kingdom, Australia, New Zealand, and internationally.
MARKSANS
₹257.85
7D
-0.9%
1Y
69.6%
Consun Pharmaceutical Group
Market Cap: HK$9.5b
Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.
1681
HK$11.42
7D
7.7%
1Y
77.1%
Aether Industries
Market Cap: ₹102.8b
Produces and sells advanced intermediates and specialty chemicals in India and internationally.
AETHER
₹801.40
7D
7.4%
1Y
0.2%
Zhejiang Garden BiopharmaceuticalLtd
Market Cap: CN¥8.2b
Zhejiang Garden Biopharmaceutical Co.,Ltd.
300401
CN¥14.79
7D
-0.2%
1Y
33.5%
Hunan Jiudian Pharmaceutical
Market Cap: CN¥8.2b
Researches, develops, produces, and sells pharmaceutical products in China and internationally.
300705
CN¥16.17
7D
4.5%
1Y
-37.3%
Acutaas Chemicals
Market Cap: ₹91.1b
Engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally.
ACUTAAS
₹1,130.00
7D
-4.2%
1Y
86.7%
Shilpa Medicare
Market Cap: ₹76.7b
Manufactures and sells active pharmaceutical ingredients (APIs), finished dosage formulations, biosimilars, recombinant albumin in India, the United States, Europe, and internationally.
530549
₹897.45
7D
0.7%
1Y
70.1%
ChengDu ShengNuo BiotecLtd
Market Cap: CN¥4.7b
Engages in the research and development, production, sale, and export of peptide drugs.
688117
CN¥41.18
7D
11.2%
1Y
71.2%
Beijing Kawin Technology Share-Holding
Market Cap: CN¥4.6b
A biopharmaceutical company, provides treatment solutions for viral and immune diseases in China.
688687
CN¥27.35
7D
-5.7%
1Y
-0.8%
Innova Captab
Market Cap: ₹50.6b
An integrated pharmaceutical company, engages in the research and development, manufacture, distribution, and marketing of drugs in India and internationally.
INNOVACAP
₹890.15
7D
2.5%
1Y
77.7%
Essex Bio-Technology
Market Cap: HK$2.8b
An investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally.
1061
HK$4.90
7D
-7.4%
1Y
92.2%